IPCALAB Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > ipcalab

Technical Analysis

Technical Strength: 4 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 47.4. According to RSI analysis, ipcalab is at it's support. 8.0 IPCALAB RSI Chart
MACD (?) MACD: 4.24 and Signal Line: 9.41. According to MACD analysis, ipcalab is marginally weak. 3.0 IPCALAB MACD Chart
Simple Moving Average (?) According to simple moving average analysis, ipcalab is facing resistance at 506 and support level is at 467.602. 3.0 IPCALAB Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, ipcalab is facing resistance at 499 and support level is at 486.7289. 7.0 IPCALAB Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.191. According to bollinger bands, ipcalab is technically weak. 3.0 IPCALAB Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, no levels identified. NA IPCALAB Fibonacci Retracement Chart
Average True Range (?) ATR: 23.8 NA IPCALAB Average True Range Chart
Average Directional Index (?) ADX is 40.3 which means IPCALAB is in a trend. NA IPCALAB Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
October 23, 2017
Open Price 500.0
High Price 504.0
Low Price 482.5
Close Price 487.9
Absolute Change -7.8
Percentage Change -1.57%
Weekly Change -2.36%
Monthly Change -14.9%
Yearly Change -21.3%
52-week high 657.6
52-week low 400.0
Corporate Actions
ExDate Purpose
July 27, 2017 AGM/DIV -RE 1 PER SHARE
August 04, 2016 ANNUAL GENERAL MEETING
July 22, 2015 AGM/DIV-RE 1 PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.39
Confidence in Beta0.678%
Market Capital Rs. 6156.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 7.25
TTM Price-to-Earnings (P/E) Ratio 67.3
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 23 October 2017: Deliverable Quantity:6.07e+04 NA IPCALAB Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 23 October 2017: Daily Volatility:0.7031 NA IPCALAB Annualized Daily Volatility (Spot Price) Chart

Announcements

August 22, 2017 IPCAppointment of AuditorsCA Laboratories Limited has informed the Exchange regarding 'Appointment of M/s G.M. Kapadia & Co. Chartered Accountants as Statutory Auditors of the Company in the Annual General Meeting held on August 04, 2017'.
August 07, 2017 IPCShareholders meetingCA Laboratories Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 04, 2017. Further, the company has informed the Exchange regarding voting results.
See all Announcements

Board Meetings

Date Meeting Date Purpose
July 27, 2017 August 11, 2017 IntResultster-alia, to take on record the Unaudited Financial Results for the 1st Quarter ended June 30, 2017 of the financial year 2017-18.
May 16, 2017 May 28, 2017 intResults/Dividendter-alia, to consider: (1). the Unaudited Financial Results for the 4th quarter and the Audited Financial Results for the financial year ended March 31, 2017; and 2. recommendation of dividend for the financial year ended March 31, 2017. Further, with reference to the above meeting of the Board of Directors, the trading window for dealing in the securities of the Company by the Insiders as defined under the SEBI (Prohibition of Insider Trading) Regulations, 2015 shall remain closed with immediate effect till closure of trading hours on May 30, 2017.
See all Board Meetings

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 457.4 Rs. 470 Rs. 478.9 Rs. 491.5 Rs. 500.4 Rs. 513 Rs. 521.9